Abstract
Positron emission tomography (PET) using \(^{18}\)F-fludeoxyglucose ([\(^{18}\)F]FDG) improves the cancer diagnosis by visualizing the pathological pathway of Warburg effect. As an analog of glucose, FDG uptake is mediated by glucose transporter (GLUT) and hexokinase (HK), which can be overexpressed under tumor hypoxia conditions. Quantitative interpretation of the images to the feature of tumor microenvironment is important to improve tumor staging and localization. However, it is usually difficult for such kind of quantitative analysis due to the complex metabolic procedure of multi-substance system within tumor. This study proposes a novel reaction-diffusion model to simulate the procedures of FDG: transported into tumor cells, catalyzed by GLUT and phosphorylated by HK leading to the production of FDG-6-phosphate (FDG6P) similar to glucose-6-phosphate (G6P). Hypoxia induced factor-1 (HIF-1) is incorporated to control the upregulations of GLUT and HK. The simulation results are compared with dynamic PET scans of nude mice with lymphoma xenograft tumors, which confirmed that the simulation can approach to real measurements. With this quantitative simulation model, the interaction of FDG to the substances, oxygen, HIF-1, glucose, G6P, and FDG6P within the tumor microenvironment is investigated under various vascularizations. By controlling the expression factor of GLUT and HK, their influences on FDG uptake is further assessed. The preliminary results of the simulation model have shown a potential to improve the quantification of FDG PET image and to assist cancer diagnosis and therapy prognosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ganapathy, V., Thangaraju, M., Prasad, P.D.: Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol. Therapeutics 121(1), 29–40 (2009)
Burgman, P., et al.: Hypoxia-induced increase in FDG uptake in MCF7 cells. J. Nucl. Med. 42(1), 170–175 (2001)
Muzi, M., et al.: Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumors. Nucl. Med. Biol. 28(2), 107–116 (2001)
Mathupala, S., Ko, Y.A., Pedersen, P.: Hexokinase II: cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncog. 25(34), 4777–4786 (2006)
Vaupel, P., Kallinowski, F., Okunieff, P.: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49(23), 6449–6465 (1989)
Vaupel, P.: Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 14(3), 198–206 (2004)
Semenza, G.L.: HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88(4), 1474–1480 (2000)
Semenza, G.L.: Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3(10), 721–732 (2003)
Airley, R., et al.: Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin. Cancer Res. 7(4), 928–934 (2001)
Zhang, J.-Z., Behrooz, A., Ismail-Beigi, F.: Regulation of glucose transport by hypoxia. Am. J. Kidney Dis. 34(1), 189–202 (1999)
Yasuda, S., et al.: Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor-1\(\alpha \) and its significance. J. Hepatol. 40(1), 117–123 (2004)
Natsuizaka, M., et al.: Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia. Exp. Cell Res. 313(15), 3337–3348 (2007)
Wolf, A., et al.: Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J. Exp. Med. 208(2), 313–326 (2011)
Chen, C., et al.: Regulation of glut1 mRNA by hypoxia-inducible factor-1 interaction between H-ras and hypoxia. J. Biol. Chem. 276(12), 9519–9525 (2001)
Konerding, M., et al.: Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts. Br. J. Cancer 80(5–6), 724 (1999)
Konerding, M., Fait, E., Gaumann, A.: 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. Br. J. Cancer 84(10), 1354 (2001)
DaÅŸu, A., Toma-DaÅŸu, I., Karlsson, M.: Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia. Phys. Med. Biol. 48(17), 2829 (2003)
Kelly, C.J., Brady, M.: A model to simulate tumour oxygenation and dynamic [18F]-Fmiso PET data. Phys. Med. Biol. 51(22), 5859 (2006)
Dalah, E., Bradley, D., Nisbet, A.: Simulation of tissue activity curves of 64Cu-ATSM for sub-target volume delineation in radiotherapy. Phys. Med. Biol. 55(3), 681 (2010)
Petit, S.F., et al.: Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study. Phys. Med. Biol. 54(7), 2179 (2009)
David, M., et al.: Modelling and simulation of [18F] fluoromisonidazole dynamics based on histology-derived microvessel maps. Phys. Med. Biol. 56(7), 2045 (2011)
Mönnich, D., et al.: Modelling and simulation of the influence of acute and chronic hypoxia on [18F] fluoromisonidazole PET imaging. Phys. Med. Biol. 57(6), 1675 (2012)
Ullah, M.S., Davies, A.J., Halestrap, A.P.: The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1\(\alpha \)-dependent mechanism. J. Biol. Chem. 281(14), 9030–9037 (2006)
Wada, H., et al.: Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1a. Liver Int. 26(4), 414–423 (2006)
Jiang, B.-H., et al.: Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J. Physiol.-Cell Physiol. 271(4), C1172–C1180 (1996)
Leedale, J., et al.: Modeling the dynamics of hypoxia inducible factor-1\(\alpha \) (HIF-1\(\alpha )\) within single cells and 3D cell culture systems. Math. Biosci. 258, 33–43 (2014)
Kelly, C., Smallbone, K., Brady, M.: Tumour glycolysis: the many faces of HIF. J. Theor. Biol. 254(2), 508–513 (2008)
Qian, W., et al.: Exploring the quantitative relationship between metabolism and enzymatic phenotype by physiological modeling of glucose metabolism and lactate oxidation in solid tumors. Phys. Med. Biol. 60(6), 2547 (2015)
Bisswanger, H.: Enzyme kinetics: Section 2.6–2.12. Enzyme Kinetics, pp. 124–193. Wiley-VCH Verlag GmbH & Co. KGaA (2008)
Vinnakota, K.C., Beard, D.A.: Kinetic analysis and design of experiments to identify the catalytic mechanism of the monocarboxylate transporter isoforms 4 and 1. Biophys. J. 100(2), 369–380 (2011)
Mueckler, M.: Facilitative glucose transporters. Eur. J. Biochem. 219(3), 713–725 (1994)
Molavian, H.R., et al.: Fingerprint of cell metabolism in the experimentally observed interstitial pH and pO2 in solid tumors. Cancer Res. 69(23), 9141–9147 (2009)
Casciari, J., Sotirchos, S., Sutherland, R.: Mathematical modelling of microenvironment and growth in EMT6/Ro multicellular tumour spheroids. Cell Prolif. 25(1), 1–22 (1992)
Casciari, J.J., Sotirchos, S.V., Sutherland, R.M.: Glucose diffusivity in multicellular tumor spheroids. Cancer Res. 48(14), 3905–3909 (1988)
Nishimura, H., et al.: Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. J. Biol. Chem. 268(12), 8514–8520 (1993)
Rivenzon-Segal, D., et al.: Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells. Am. J. Physiol.-Endocrinol. Metab. 279(3), E508–E519 (2000)
RodrÃguez-EnrÃquez, S., et al.: Kinetics of transport and phosphorylation of glucose in cancer cells. J. Cell. Physiol. 221(3), 552–559 (2009)
Smith, T.A., et al.: Decreased [18F] fluoro-2-deoxy-d-glucose incorporation and increased glucose transport are associated with resistance to 5FU in MCF7 cells in vitro. Nucl. Med. Biol. 34(8), 955–960 (2007)
MarÃn-Hernández, A., et al.: Determining and understanding the control of glycolysis in fast-growth tumor cells. FEBS J. 273(9), 1975–1988 (2006)
Höckel, M., et al.: Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements. Cancer Res. 51(22), 6098–6102 (1991)
Vaupel, P., et al.: Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 51(12), 3316–3322 (1991)
Lee, T.S., et al.: Comparison of 18 F-FDG, 18 F-FET and 18 F-FLT for differentiation between tumor and inflammation in rats. Nucl. Med. Biol. 36(6), 681–686 (2009)
Piert, M., et al.: Positron detection for the intraoperative localisation of cancer deposits. Eur. J. Nucl. Med. Mol. Imaging 34(10), 1534–1544 (2007)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Wang, Q., Liu, Z., Ziegler, S.I., Shi, K. (2015). A Reaction-Diffusion Simulation Model of [\(^{18}\)F]FDG PET Imaging for the Quantitative Interpretation of Tumor Glucose Metabolism. In: Gao, F., Shi, K., Li, S. (eds) Computational Methods for Molecular Imaging. Lecture Notes in Computational Vision and Biomechanics, vol 22. Springer, Cham. https://doi.org/10.1007/978-3-319-18431-9_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-18431-9_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18430-2
Online ISBN: 978-3-319-18431-9
eBook Packages: EngineeringEngineering (R0)